Accessibility Menu
Azenta Stock Quote

Azenta (NASDAQ: AZTA)

$31.71
(-0.3%)
-0.10
Price as of October 22, 2025, 4:00 p.m. ET

KEY DATA POINTS

Current Price
$31.71
Daily Change
(-0.3%) $0.10
Day's Range
$31.31 - $32.16
Previous Close
$31.71
Open
$31.56
Beta
1.57
Volume
418,226
Average Volume
607,549
Market Cap
1.5B
Market Cap / Employee
$31.81M
52wk Range
$23.91 - $55.64
Revenue
-
Gross Margin
0.43%
Dividend Yield
N/A
EPS
-$2.43
CAPs Rating
-
Industry
Life Sciences Tools and Services

The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More

Azenta Return vs. S&P

1 Year5 Year5 Year AnnualizedSince IPO
AZTA-27.34%-34.49%-8.11%+305%
S&P+14.5%+93.32%+14.09%+1,317%

Azenta Company Info

Azenta, Inc. is a provider of life sciences sample exploration and management solutions for the life sciences market. It operates through the Life Sciences Products and Life Sciences Services segments. The Life Sciences Products segment is involved in automated cold storage solutions for biological and chemical compound samples. The Life Sciences Services segment focuses on the solutions addressing the many needs of customers in the area of genomic analysis and the management and care of biological samples used in pharmaceutical, biotech, healthcare, clinical, and academic research, and development markets. The company was founded in 1978 and is headquartered in Burlington, MA.

News & Analysis

Financial Health

General

Q2 2025YOY Change
Revenue$143.94M-16.7%
Gross Profit$67.76M8.5%
Gross Margin47.07%10.9%
Market Cap$1.41B-50.3%
Market Cap / Employee$0.47M-42.1%
Employees3K0.0%
Net Income$0.68M110.3%
EBITDA$16.30M63.1%

Currently no data to display

Revenue Growth Rate

Currently no data to display.

Earnings Per Share Growth Rate

Currently no data to display.

Assets

Q2 2025YOY Change
Net Cash$272.35M-19.7%
Accounts Receivable$164.64M-15.4%
Inventory80.5-30.2%

Liabilities

Q2 2025YOY Change
Long Term Debt$52.63M-13.2%
Short Term Debt$0.00M-100.0%

Ratios

Q2 2025YOY Change
Return On Assets-1.47%4.3%
Return On Invested Capital-2.78%-2.0%

Cash Flow

Q2 2025YOY Change
Free Cash Flow$14.97M411.8%
Operating Free Cash Flow$25.81M1341.1%

Valuation

MetricQ3 2024Q4 2024Q1 2025Q2 2025YoY Change
Price to Book1.231.290.920.83-35.95%
Price to Sales3.553.512.502.33-44.95%
Price to Tangible Book Value2.312.751.701.55-31.15%
Price to Free Cash Flow TTM180.58111.6561.1730.85-54.68%
Enterprise Value to EBITDA150.83293.21199.1569.96-69.06%
Free Cash Flow Yield0.6%0.9%1.6%3.2%120.68%
Return on Equity-7.6%-7.6%-2.0%-1.7%-73.75%
Total Debt$70.68M$54.34M$53.70M$52.63M-26.28%

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.